RSMDF News and Press, Resmed Inc Ord

2024-07-03 08:44:13 ET Summary RMD's competitive advantages in the sleep domain are durable, and its underlying business remains strong. It looks attractively valued based on future growth opportunities, resilient returns on capital, and potential for multiple expansions. A ma...

2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...

2024-04-25 21:38:02 ET ResMed Inc. (RMD) Q3 2024 Earnings Conference Call April 25, 2024, 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial O...

2024-01-24 22:56:04 ET ResMed Inc. (RMD) Q2 2024 Earnings Conference Call January 24, 2024 04:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Michael Farrell - Chief Executive Officer Brett Sandercock - Chief Financ...

2024-01-09 12:38:56 ET Summary Today, we take our first look at ResMed Inc., a San Diego-based company with two primary business segments: Sleep and Respiratory Care, and Software as a Service. The company's products and services are aimed at a huge global market and ResMed is see...

2023-10-27 23:25:41 ET Summary ResMed's share price has fallen by over 40% since highs hit in April 2023. GLP-1 weight-loss drugs are expected to reduce demand for ResMed's products that treat obstructive sleep apnea. FY23 operating conditions were very favourable for ResMed a...

2023-10-26 21:52:09 ET ResMed Inc. (RMD) Q1 2024 Results Conference Call October 26, 2023 04:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial ...

2023-09-09 08:15:00 ET Summary Morningstar's moat indexes have a history of outperforming the S&P 500 over long holding periods. The Moat Index underperformed the S&P 500 by 2% in August, but remains ahead by 500 basis points for the year. Smaller-cap companies had mor...

2023-08-11 06:33:59 ET Summary Companies with a track record of increasing dividends usually perform better. Lists of upcoming dividend increases provide valuable insights for investors. Historical returns show that some companies outperformed the benchmark ETF. Dividend K...

2023-08-03 21:13:07 ET ResMed, Inc. (RMD) Q4 2023 Earnings Conference Call August 3, 2023, 4:30 pm ET Company Participants Amy Wakeham - Chief Communications & IRO Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President & COO Lucile Blai...